Dr. Frederick Lansigan, MD

  • Lebanon, NH
  • Hematologist and oncologist
NPI1548436520PAC ID6103971130
Medicare services, 2024
584
Medicare patients, 2024
204
Part D claims, 2024
380
Publications
60
Clinical trials
9
Practice address
1 Medical Center Drive, Lebanon, NH 03756
Practice phone
Call (603) 650-5000
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Dartmouth Hitchcock Medical Center

Hospital · Lebanon, New Hampshire

See all 4 affiliations

Find Dr. Lansigan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Frederick Lansigan is a hematologist and oncologist in Lebanon, New Hampshire

Dr. Lansigan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health.

Dr. Lansigan's NPI, 1548436520, was assigned on April 30, 2008. Dr. Lansigan graduated from SUNY Downstate Health Sciences University in 2002. Dr. Lansigan holds New Hampshire license 14513.

NPI and contact details
Medicare PAC ID
6103971130
NPI enumeration date
April 30, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Practice phone
(603) 650-5000
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Frederick Lansigan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire

Dr. Lansigan's primary practice is Dartmouth Hitchcock Medical Center, at 1 Medical Center Drive, Lebanon, NH 03756 in Grafton County. The practice phone is (603) 650-5000.

Source: Dmand AI Affiliation Data

Dr. Frederick Lansigan is affiliated with 2 sites of care and 2 medical groups

Dr. Lansigan's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dr. Lansigan is also affiliated with Cheshire Medical Center. The medical group on file is Dartmouth Hitchcock Medical Center. Dmand AI also links Dr. Lansigan to 1 more medical group, named with a free account. Dr. Lansigan's employer is on file too: a hospital.

See all 4 affiliations for Dr. Lansigan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Frederick Lansigan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lansigan practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Dartmouth Hitchcock Medical CenterAvailable with a free account
+1 more site and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Lansigan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across Dartmouth-Hitchcock Health and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Frederick Lansigan is one of 67 hematologists and oncologists in New Hampshire

Hematology and oncology is Dr. Lansigan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Lansigan is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Lansigan's licenses on file in 4 states: New Hampshire, Maine, Connecticut and New York.

Specialties and state licenses

  • Hematology and oncology, New HampshirePrimaryLicense 14513 · 2009 to 2027 · taxonomy 207RH0003X
  • Maine license2020 to 2021
  • Connecticut license2006 to 2008
  • New York license2004 to 2008

Clinical focus

Dmand AI lists chronic anemia, chronic leukemia, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Lansigan treats.

Hematologists and oncologists near Dr. Lansigan

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Frederick Lansigan billed Medicare for 584 services in 2024

CMS data shows 584 Medicare services from Dr. Lansigan across 5 procedure codes in 2024, for 204 Medicare patients. Medicare paid $48,489 for them. Every service was in a facility, such as a hospital, rather than an office.

Medicare services, 2024584
Medicare patients204
Paid by Medicare$48,489
Procedure codes5

Dr. Lansigan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 3822024: 54342%
Other services
2023: 02024: 41

Dr. Lansigan compared with the New Hampshire median for hematologists and oncologists, 2024

  • Dr. Lansigan
  • New Hampshire median
Medicare services
584vs 576Close to median
Medicare patients
204vs 24316% below
Part D claims
294vs 21338% above

Medians across 65 hematologists and oncologists in New Hampshire with Dmand AI profiles that report each measure.

Dr. Lansigan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Lansigan

Need commercial claims for Dr. Lansigan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lansigan and other hematologists and oncologists in New Hampshire.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Frederick Lansigan treated 204 Medicare patients in 2024, average age 74

CMS counts 204 Medicare patients who saw Dr. Lansigan in 2024. The largest group is 65 to 74, with 90 patients. 70% of them have high blood pressure, and 61% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lansigan's median patient age at 66, with 43% women.

Medicare patients, 2024204
Average age74
Average risk score1.99
Also on Medicaid11%

Dr. Lansigan's Medicare patients by age, 2024

Dr. Lansigan's Medicare patients by sex, 2024

  • Women9245%
  • Men11255%

Chronic conditions among Dr. Lansigan's Medicare patients, 2024

  1. High blood pressure70%
  2. High cholesterol61%
  3. Arthritis35%
  4. Anxiety31%
  5. Mood disorders28%
  6. Chronic kidney disease25%
  7. Diabetes25%
  8. Ischemic heart disease25%

Share of Medicare patients with each condition. A patient can have several.

Dr. Lansigan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 66

Patient panel by sex, all payers

  • Women43%
  • Men57%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Frederick Lansigan wrote 380 Medicare Part D claims in 2024

In 2024, Dr. Lansigan wrote 380 Medicare Part D claims for 51 patients. 86% of them were for generic drugs. CMS names the drug for 294 of them, across 12 drugs with 11 or more claims each, at $484,187 in total drug cost. In 2023, CMS named 260 claims across 9 drugs.

Part D claims, 2024380
Drugs named by CMS12
Total drug cost$484,187
Part D patients51

Dr. Lansigan's Part D claims by kind of drug, 2024

  • Generic327 claims86%
  • Brand-name53 claims14%

Dr. Lansigan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Lansigan's Part D claims, 2024

  • Antibiotics12%46 of 380 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 2602024: 29413%

Drugs named by CMS: 12 in 2024, 9 in 2023.

See all prescribing by Dr. Lansigan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Frederick Lansigan scored 80 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Lansigan for performance year 2024, reported through an alternative payment model (APM). Dr. Lansigan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lansigan as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Lansigan's MIPS scores, performance year 2024

  • 80of 100Final score
  • 53.5of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Lansigan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Frederick Lansigan has 60 publications on record

Dmand AI links 60 papers to Dr. Lansigan, published from 2008 to 2024. 2020 was the busiest year, with 9. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols, Leukemia, Lymphocytic, Chronic, B-Cell and Antineoplastic Agents. Dr. Lansigan has published most often in J Cutan Pathol. Dr. Lansigan's most frequent co-authors are Stephen J. Schuster, MD, John Nathan Allan, MD and Paul Michael Barr, MD.

Papers60
Years published2008 to 2024

Dr. Lansigan's papers by year, 2015 to 2024

Topics Dr. Lansigan writes about most

  • Antineoplastic Combined Chemotherapy Protocols
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Antineoplastic Agents
  • Rituximab
  • Skin Neoplasms
  • Antibodies, Monoclonal
  • Diagnosis, Differential
  • Doxorubicin

Dr. Lansigan's most frequent co-authors

Recent publications by Dr. Lansigan

See all 60 publications and co-authors

See who Dr. Lansigan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lansigan works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Frederick Lansigan has worked on 9 clinical trials

Dmand AI links Dr. Lansigan to 9 clinical trials, 3 of them phase 1/2 studies. 2 are still active or recruiting. Conditions studied include Lymphoma, B-Cell, Lymphoma, Non-Hodgkin and Lymphoma, T-Cell, Cutaneous. Dartmouth-Hitchcock Medical Center sponsors the most, 4. Open Payments lists research payments to Dr. Lansigan that name 1 trial.

Clinical trials with Dr. Lansigan by phase

  1. NonePhase 1: no trials
  2. 3Phase 1/2: 3 trials
  3. 1Phase 2: 1 trial
  4. 1Phase 3: 1 trial
  5. NonePhase 4: no trials

Conditions in Dr. Lansigan's trials

  • Lymphoma, B-Cell
  • Lymphoma, Non-Hodgkin
  • Lymphoma, T-Cell, Cutaneous
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Lymphoma, Follicular

Investigators on the most trials with Dr. Lansigan

Recent clinical trials with Dr. Lansigan

See all 9 clinical trials and co-investigators

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Frederick Lansigan received $48,368 in industry payments from 2016 to 2025

CMS Open Payments shows 106 general payments to Dr. Lansigan from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 42% of the total. Seagen Inc. paid the most, $12,918. It also lists 4 research payments totaling $5,172 from 2016 to 2017, naming 1 clinical trial.

General payments to Dr. Lansigan by program year, 2016 to 2025

General payments to Dr. Lansigan by kind, 2016 to 2025

$48.4Kin total
  • Consulting fees$20,34342%
  • Honoraria$11,00023%
  • Travel and lodging$7,00314%
  • Speaker and faculty fees$6,00012%
  • Other$4,0238%

Companies that paid Dr. Lansigan the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lansigan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Frederick Lansigan has 1 award and honors on record

Dmand AI lists 1 award for Dr. Lansigan, most recently CMS Stage 1 EHR in 2013.

Awards and honors for Dr. Lansigan

  1. 2013
    • CMS Stage 1 EHR

Source: Dmand AI Professional Profile Data

Dr. Frederick Lansigan graduated from SUNY Downstate Health Sciences University

Dr. Lansigan graduated from SUNY Downstate Health Sciences University in 2002. Dr. Lansigan is a member of ASCO.

  1. Medical schoolSUNY Downstate Health Sciences University
  2. Board certified in hematologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Frederick Lansigan accepts plans from 14 insurance carriers

Dr. Lansigan is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

  • Aetna
  • Excellus BlueCross BlueShield
  • Blue Cross Blue Shield of Michigan
  • United Healthcare
  • Blue Cross Blue Shield of Massachusetts
  • Cigna
  • Elevance
  • HCSC
  • +6 more carriersWith a free account

Plan types Dr. Lansigan accepts, by number of carriers

  1. PPO9
  2. Medicare8
  3. HMO7
  4. POS4
  5. EPO3
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Frederick Lansigan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Frederick Lansigan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Frederick Lansigan's NPI number?

Dr. Frederick Lansigan's NPI number is 1548436520. It was assigned on April 30, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. Frederick Lansigan?

Dr. Frederick Lansigan is a hematologist and oncologist in Lebanon, New Hampshire. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Frederick Lansigan practice?

Dr. Lansigan practices at 1 Medical Center Drive, Lebanon, NH 03756. Dr. Lansigan's primary practice is Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire, part of Dartmouth-Hitchcock Health. Dmand AI also links Dr. Lansigan to 1 medical group.

What is Dr. Frederick Lansigan's office phone number?

The practice phone on file for Dr. Lansigan is (603) 650-5000.

What is Dr. Frederick Lansigan's medical license number?

Dr. Lansigan holds New Hampshire license 14513, one of the licenses on file in 4 states.

Which states has Dr. Frederick Lansigan been licensed in?

Dmand AI has state licenses on file for Dr. Lansigan in New Hampshire (2009 to 2027), Maine (2020 to 2021), Connecticut (2006 to 2008) and New York (2004 to 2008).

Which hospitals is Dr. Frederick Lansigan affiliated with?

Dr. Lansigan practices at Dartmouth Hitchcock Medical Center in Lebanon, New Hampshire. Dr. Lansigan is also affiliated with Cheshire Medical Center.

What medical group is Dr. Frederick Lansigan part of?

Dr. Lansigan is linked to Dartmouth Hitchcock Medical Center. Dmand AI links Dr. Lansigan to 1 more medical group.

Does Dr. Frederick Lansigan accept Medicare?

Yes. CMS data shows Dr. Lansigan billed Medicare for 584 services in 2024, and Dr. Lansigan accepts Medicare assignment.

Does Dr. Frederick Lansigan offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Lansigan as offering telehealth services.

Show 11 more questionsShow fewer questions

What is Dr. Frederick Lansigan's MIPS score?

Dr. Lansigan's MIPS final score for performance year 2024 is 80 out of 100, reported through an alternative payment model (APM).

How many Medicare patients does Dr. Frederick Lansigan see?

CMS counts 204 Medicare patients who saw Dr. Lansigan in 2024, with an average age of 74.

Is Dr. Frederick Lansigan board certified?

Yes. Dr. Lansigan is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Frederick Lansigan bill to Medicare?

In 2024, Dr. Lansigan's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99215) and office visit, established patient (99214).

Where did Dr. Frederick Lansigan go to medical school?

Dr. Lansigan graduated from SUNY Downstate Health Sciences University in 2002.

What drugs does Dr. Frederick Lansigan prescribe most?

In 2024 Medicare Part D data, Dr. Lansigan's most prescribed drugs by claims were Bexarotene, Acyclovir and Levothyroxine Sodium.

Has Dr. Frederick Lansigan received payments from drug or device companies?

CMS Open Payments shows $48,368 in general payments to Dr. Lansigan from 22 companies from 2016 to 2025. The largest total came from Seagen Inc.

How long has Dr. Frederick Lansigan been practicing?

Dr. Lansigan graduated from medical school in 2002, 24 years ago.

Does Dr. Frederick Lansigan do research?

Dmand AI links 60 publications to Dr. Lansigan, published from 2008 to 2024. Dr. Lansigan has worked on 9 clinical trials.

Who does Dr. Frederick Lansigan publish with?

Dr. Lansigan's most frequent co-authors are Stephen J. Schuster, MD (8 shared papers), John Nathan Allan, MD (7 shared papers) and Paul Michael Barr, MD (7 shared papers).

What insurance does Dr. Frederick Lansigan accept?

Dr. Lansigan is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in New Hampshire by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)